VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q43151311 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010834.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q43151311‏
024 ‎‡a 0000-0001-7915-2506‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q43151311‏
100 0 ‎‡a Lise Lotte Hansen‏ ‎‡9 sl‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Lise Lotte Hansen‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Lise Lotte Hansen‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Lise Lotte Hansen‏ ‎‡c investigadora‏ ‎‡9 es‏
400 0 ‎‡a Lise Lotte Hansen‏ ‎‡c investigadora‏ ‎‡9 ast‏
670 ‎‡a Author's A nine-nucleotide deletion and splice variation in the coding region of the interferon induced ISG12 gene‏
670 ‎‡a Author's A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?‏
670 ‎‡a Author's Allelic imbalance in selected chromosomal regions in ovarian cancer‏
670 ‎‡a Author's Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer‏
670 ‎‡a Author's Assignment of the human translation termination factor 1‏
670 ‎‡a Author's Assignment of the human translation termination factor 1 (ETF1) to 5q31.1 and of the proximal marker D5S1995 by radiation hybrid mapping‏
670 ‎‡a Author's Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine‏
670 ‎‡a Author's Author's reply: To PMID 23159593.‏
670 ‎‡a Author's Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.‏
670 ‎‡a Author's Competitive amplification of differentially melting amplicons‏
670 ‎‡a Author's Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.‏
670 ‎‡a Author's Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer‏
670 ‎‡a Author's Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers‏
670 ‎‡a Author's Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors‏
670 ‎‡a Author's Effect of the FSH receptor single nucleotide polymorphisms‏
670 ‎‡a Author's Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles‏
670 ‎‡a Author's ELMO3: a direct driver of cancer metastasis?‏
670 ‎‡a Author's Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations‏
670 ‎‡a Author's Familial cancer associated with a polymorphism in ARLTS1‏
670 ‎‡a Author's Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA)‏
670 ‎‡a Author's Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer‏
670 ‎‡a Author's Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients‏
670 ‎‡a Author's High-Resolution Melting Analysis for Mutation Screening of RGSL1, RGS16, and RGS8 in Breast Cancer‏
670 ‎‡a Author's Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.‏
670 ‎‡a Author's Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis.‏
670 ‎‡a Author's Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas‏
670 ‎‡a Author's Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases‏
670 ‎‡a Author's IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope‏
670 ‎‡a Author's Improved reproducibility in genome-wide DNA methylation analysis for PAXgene-fixed samples compared with restored formalin-fixed and paraffin-embedded DNA.‏
670 ‎‡a Author's Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products‏
670 ‎‡a Author's LOH rather than genotypes ofTP53codon 72 is associated with disease-free survival in primary breast cancer‏
670 ‎‡a Author's Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events‏
670 ‎‡a Author's Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement‏
670 ‎‡a Author's Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene‏
670 ‎‡a Author's No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls.‏
670 ‎‡a Author's Polymorphisms in the human X-linked pyruvate dehydrogenase E1 alpha gene‏
670 ‎‡a Author's Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations‏
670 ‎‡a Author's Pyruvate dehydrogenase deficiency caused by a 33 base pair duplication in the PDH E1 alpha subunit.‏
670 ‎‡a Author's Pyruvate dehydrogenase deficiency caused by a 5 base pair duplication in the E1 alpha subunit‏
670 ‎‡a Author's Refined localization of the pyruvate dehydrogenase E1 alpha gene‏
670 ‎‡a Author's Refined localization of the pyruvate dehydrogenase E1 alpha gene (PDHA1) by linkage analysis‏
670 ‎‡a Author's Sensitive and fast mutation detection by solid phase chemical cleavage‏
670 ‎‡a Author's Size matters: Associations between the androgen receptor CAG repeat length and the intrafollicular hormone milieu.‏
670 ‎‡a Author's The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM‏
670 ‎‡a Author's The role of innate immunity in atherogenesis‏
670 ‎‡a Author's TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer‏
670 ‎‡a Author's X-linked pyruvate dehydrogenase E1 alpha subunit deficiency in heterozygous females: variable manifestation of the same mutation‏
909 ‎‡a (orcid) 0000000179152506‏ ‎‡9 1‏
919 ‎‡a effectofthefshreceptorsinglenucleotidepolymorphismsfshr307680onthefollicularfluidhormoneprofileandthegranulosacellgeneexpressioninhumansmallantralfollicles‏ ‎‡A Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles‏ ‎‡9 1‏
919 ‎‡a mutationsandpolymorphismsinthepyruvatedehydrogenasee1alphagene‏ ‎‡A Mutations and polymorphisms in the pyruvate dehydrogenase E1 alpha gene‏ ‎‡9 1‏
919 ‎‡a moleculargeneticanalysisofeasilyaccessiblebreasttumourdnapurifiedfromtissueleftoverfromhormonereceptormeasurement‏ ‎‡A Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement‏ ‎‡9 1‏
919 ‎‡a effectofthefshreceptorsinglenucleotidepolymorphisms‏ ‎‡A Effect of the FSH receptor single nucleotide polymorphisms‏ ‎‡9 1‏
919 ‎‡a comprehensivegenomemethylationanalysisinbladdercanceridentificationandvalidationofnovelmethylatedgenesandapplicationoftheseasurinarytumormarkers‏ ‎‡A Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers‏ ‎‡9 1‏
919 ‎‡a polymorphismsinthehuman10linkedpyruvatedehydrogenasee1alphagene‏ ‎‡A Polymorphisms in the human X-linked pyruvate dehydrogenase E1 alpha gene‏ ‎‡9 1‏
919 ‎‡a publishercorrectionepigeneticchangesinmyelofibrosisdistinctmethylationchangesinthemyeloidcompartmentsandincaseswithasxl1mutations‏ ‎‡A Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations‏ ‎‡9 1‏
919 ‎‡a copynumbervariationsaltermethylationandparalleligf2overexpressioninadrenaltumors‏ ‎‡A Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors‏ ‎‡9 1‏
919 ‎‡a chromosome1q253copynumberalterationsinprimarybreastcancersdetectedbymultiplexligationdependentprobeamplificationandallelicimbalanceassaysanditscomparisonwithfluorescentinsituhybridizationassays‏ ‎‡A Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.‏ ‎‡9 1‏
919 ‎‡a identificationofaccuratereferencegenesforrtqpcranalysisofformalinfixedparaffinembeddedtissuefromprimarynonsmallcelllungcancersandbrainandlymphnodemetastases‏ ‎‡A Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases‏ ‎‡9 1‏
919 ‎‡a ighv169encodedantibodiesexpressedinchroniclymphocyticleukemiareactwithmalondialdehydeacetaldehydeadductanimmunodominantoxidationspecificepitope‏ ‎‡A IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope‏ ‎‡9 1‏
919 ‎‡a pyruvatedehydrogenasedeficiencycausedbya33basepairduplicationinthepdhe1alphasubunit‏ ‎‡A Pyruvate dehydrogenase deficiency caused by a 33 base pair duplication in the PDH E1 alpha subunit.‏ ‎‡9 1‏
919 ‎‡a pyruvatedehydrogenasedeficiencycausedbya5basepairduplicationinthee1alphasubunit‏ ‎‡A Pyruvate dehydrogenase deficiency caused by a 5 base pair duplication in the E1 alpha subunit‏ ‎‡9 1‏
919 ‎‡a refinedlocalizationofthepyruvatedehydrogenasee1alphagene‏ ‎‡A Refined localization of the pyruvate dehydrogenase E1 alpha gene‏ ‎‡9 1‏
919 ‎‡a refinedlocalizationofthepyruvatedehydrogenasee1alphagenepdha1bylinkageanalysis‏ ‎‡A Refined localization of the pyruvate dehydrogenase E1 alpha gene (PDHA1) by linkage analysis‏ ‎‡9 1‏
919 ‎‡a improvedreproducibilityingenomewidednamethylationanalysisforpaxgenefixedsamplescomparedwithrestoredformalinfixedandparaffinembeddeddna‏ ‎‡A Improved reproducibility in genome-wide DNA methylation analysis for PAXgene-fixed samples compared with restored formalin-fixed and paraffin-embedded DNA.‏ ‎‡9 1‏
919 ‎‡a identificationandcharacterizationoflocusspecificmethylationpatternswithinnovellociundergoinghypermethylationduringbreastcancerpathogenesis‏ ‎‡A Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis.‏ ‎‡9 1‏
919 ‎‡a increasedsensitivityofkrasmutationdetectionbyhighresolutionmeltinganalysisofcoldpcrproducts‏ ‎‡A Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products‏ ‎‡9 1‏
919 ‎‡a lohratherthangenotypesoftp53codon72isassociatedwithdiseasefreesurvivalinprimarybreastcancer‏ ‎‡A LOH rather than genotypes ofTP53codon 72 is associated with disease-free survival in primary breast cancer‏ ‎‡9 1‏
919 ‎‡a methylationofcancerrelatedgenesintumorandperipheralblooddnafromthesamebreastcancerpatientas2independentevents‏ ‎‡A Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events‏ ‎‡9 1‏
919 ‎‡a sensitiveandfastmutationdetectionbysolidphasechemicalcleavage‏ ‎‡A Sensitive and fast mutation detection by solid phase chemical cleavage‏ ‎‡9 1‏
919 ‎‡a sizemattersassociationsbetweentheandrogenreceptorcagrepeatlengthandtheintrafollicularhormonemilieu‏ ‎‡A Size matters: Associations between the androgen receptor CAG repeat length and the intrafollicular hormone milieu.‏ ‎‡9 1‏
919 ‎‡a hypomethylationandincreasedexpressionoftheputativeoncogeneelmo3areassociatedwithlungcancerdevelopmentandmetastasesformation‏ ‎‡A Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.‏ ‎‡9 1‏
919 ‎‡a highresolutionmeltinganalysisformutationscreeningofrgsl1rgs16andrgs8inbreastcancer‏ ‎‡A High-Resolution Melting Analysis for Mutation Screening of RGSL1, RGS16, and RGS8 in Breast Cancer‏ ‎‡9 1‏
919 ‎‡a roleofinnateimmunityinatherogenesis‏ ‎‡A The role of innate immunity in atherogenesis‏ ‎‡9 1‏
919 ‎‡a tp53mutationisanindependentprognosticmarkerforpooroutcomeinbothnodenegativeandnodepositivebreastcancer‏ ‎‡A TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer‏ ‎‡9 1‏
919 ‎‡a assignmentofthehumantranslationterminationfactor1etf1to5q311andoftheproximalmarkerd5s1995byradiationhybridmapping‏ ‎‡A Assignment of the human translation termination factor 1 (ETF1) to 5q31.1 and of the proximal marker D5S1995 by radiation hybrid mapping‏ ‎‡9 1‏
919 ‎‡a heterogeneityintheclinicalphenotypeoftp53mutationsinbreastcancerpatients‏ ‎‡A Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients‏ ‎‡9 1‏
919 ‎‡a assignmentofthehumantranslationterminationfactor1‏ ‎‡A Assignment of the human translation termination factor 1‏ ‎‡9 1‏
919 ‎‡a germlinemutationinrnaselpredictsincreasedriskofheadandneckuterinecervixandbreastcancer‏ ‎‡A Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer‏ ‎‡9 1‏
919 ‎‡a genotypingcommonfshrpolymorphismsbasedoncompetitiveamplificationofdifferentiallymeltingampliconscadma‏ ‎‡A Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA)‏ ‎‡9 1‏
919 ‎‡a influenceofdnadegradationinformalinfixedparaffinembeddedffpetissueonlocusspecificmethylationassessmentbymshrm‏ ‎‡A The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM‏ ‎‡9 1‏
919 ‎‡a alleliclossof16q232242isanindependentmarkerofgoodprognosisinprimarybreastcancer‏ ‎‡A Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer‏ ‎‡9 1‏
919 ‎‡a allelicimbalanceinselectedchromosomalregionsinovariancancer‏ ‎‡A Allelic imbalance in selected chromosomal regions in ovarian cancer‏ ‎‡9 1‏
919 ‎‡a roleforimmunohistochemicaldetectionofbrafv600epriortobrafinhibitortreatmentofmalignantmelanoma‏ ‎‡A A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?‏ ‎‡9 1‏
919 ‎‡a 9nucleotidedeletionandsplicevariationinthecodingregionoftheinterferoninducedisg12gene‏ ‎‡A A nine-nucleotide deletion and splice variation in the coding region of the interferon induced ISG12 gene‏ ‎‡9 1‏
919 ‎‡a competitiveamplificationofdifferentiallymeltingamplicons‏ ‎‡A Competitive amplification of differentially melting amplicons‏ ‎‡9 1‏
919 ‎‡a familialcancerassociatedwithapolymorphisminarlts1‏ ‎‡A Familial cancer associated with a polymorphism in ARLTS1‏ ‎‡9 1‏
919 ‎‡a atheroprotectiveimmunizationwithmalondialdehydemodifiedldlishaptenspecificanddependentonadvancedmdaadductsimplicationsfordevelopmentofanatheroprotectivevaccine‏ ‎‡A Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine‏ ‎‡9 1‏
919 ‎‡a 10linkedpyruvatedehydrogenasee1alphasubunitdeficiencyinheterozygousfemalesvariablemanifestationofthesamemutation‏ ‎‡A X-linked pyruvate dehydrogenase E1 alpha subunit deficiency in heterozygous females: variable manifestation of the same mutation‏ ‎‡9 1‏
919 ‎‡a epigeneticchangesinmyelofibrosisdistinctmethylationchangesinthemyeloidcompartmentsandincaseswithasxl1mutations‏ ‎‡A Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations‏ ‎‡9 1‏
919 ‎‡a competitiveamplificationofdifferentiallymeltingampliconscadmaenablessensitiveanddirectdetectionofallmutationtypesbyhighresolutionmeltinganalysis‏ ‎‡A Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.‏ ‎‡9 1‏
919 ‎‡a authorsreplytopmid23159593‏ ‎‡A Author's reply: To PMID 23159593.‏ ‎‡9 1‏
919 ‎‡a identificationandvalidationofhighlyfrequentcpgislandhypermethylationincolorectaladenomasandcarcinomas‏ ‎‡A Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas‏ ‎‡9 1‏
919 ‎‡a competitiveamplificationofdifferentiallymeltingampliconscadmaimproveskrashotspotmutationtestingincolorectalcancer‏ ‎‡A Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer‏ ‎‡9 1‏
919 ‎‡a nodifferenceinthefrequencyoflocusspecificmethylationintheperipheralblooddnaofwomendiagnosedwithbreastcancerandagematchedcontrols‏ ‎‡A No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls.‏ ‎‡9 1‏
919 ‎‡a elmo3adirectdriverofcancermetastasis‏ ‎‡A ELMO3: a direct driver of cancer metastasis?‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 JPG|500143948‏
996 ‎‡2 DBC|87097968247799‏
996 ‎‡2 ISNI|0000000487585119‏
996 ‎‡2 DBC|87097968397642‏
996 ‎‡2 BIBSYS|9014076‏
996 ‎‡2 DBC|87097968392071‏
996 ‎‡2 J9U|987008729681105171‏
996 ‎‡2 BIBSYS|5098410‏
996 ‎‡2 BIBSYS|90310662‏
996 ‎‡2 ISNI|0000000365165212‏
996 ‎‡2 SELIBR|176461‏
996 ‎‡2 NKC|xx0160283‏
996 ‎‡2 ISNI|0000000427611899‏
996 ‎‡2 BIBSYS|9065437‏
996 ‎‡2 LC|no2013113063‏
996 ‎‡2 DBC|87097919137589‏
996 ‎‡2 BIBSYS|13057607‏
996 ‎‡2 BIBSYS|8030810‏
996 ‎‡2 LC|no2018149094‏
996 ‎‡2 ISNI|0000000384653801‏
996 ‎‡2 BIBSYS|90683623‏
996 ‎‡2 SUDOC|120356066‏
996 ‎‡2 ISNI|000000042013644X‏
996 ‎‡2 DBC|87097919077527‏
996 ‎‡2 LC|no2007045722‏
996 ‎‡2 LC|no2021095386‏
996 ‎‡2 W2Z|10003194‏
996 ‎‡2 ISNI|0000000052744555‏
996 ‎‡2 BIBSYS|3377‏
996 ‎‡2 SUDOC|262188643‏
996 ‎‡2 BIBSYS|5034220‏
996 ‎‡2 ISNI|0000000487373124‏
996 ‎‡2 BIBSYS|90120434‏
996 ‎‡2 SZ|117123385X‏
996 ‎‡2 BIBSYS|1581514959491‏
996 ‎‡2 LNB|LNC10-000198052‏
996 ‎‡2 LC|no2004075106‏
996 ‎‡2 ISNI|0000000050517500‏
996 ‎‡2 ISNI|0000000428910030‏
996 ‎‡2 DBC|87097968392209‏
996 ‎‡2 ISNI|0000000497343834‏
996 ‎‡2 SUDOC|128521899‏
996 ‎‡2 SUDOC|075974193‏
996 ‎‡2 BIBSYS|90734756‏
996 ‎‡2 ISNI|0000000443102744‏
996 ‎‡2 LIH|LNB:_b_JI;=BL‏
996 ‎‡2 DBC|87097969205232‏
996 ‎‡2 W2Z|11003874‏
996 ‎‡2 DNB|1201386527‏
996 ‎‡2 ISNI|0000000357525775‏
996 ‎‡2 BIBSYS|6093689‏
996 ‎‡2 BIBSYS|1479731351118‏
996 ‎‡2 BIBSYS|7014965‏
996 ‎‡2 NUKAT|n 2018282456‏
996 ‎‡2 BIBSYS|10003194‏
996 ‎‡2 NUKAT|n 2012164117‏
996 ‎‡2 ISNI|0000000369723234‏
996 ‎‡2 LC|n 2011073850‏
996 ‎‡2 W2Z|13048593‏
996 ‎‡2 DBC|87097968962315‏
996 ‎‡2 LC|n 2009076198‏
996 ‎‡2 BIBSYS|90352800‏
996 ‎‡2 ISNI|0000000046276003‏
996 ‎‡2 DNB|138521514‏
996 ‎‡2 LC|no2022063672‏
996 ‎‡2 ISNI|000000008138355X‏
996 ‎‡2 NSK|000237616‏
996 ‎‡2 DBC|87097968981905‏
996 ‎‡2 BIBSYS|90527065‏
996 ‎‡2 DBC|87097919246965‏
996 ‎‡2 DBC|87097919374548‏
996 ‎‡2 ISNI|0000000075874862‏
996 ‎‡2 NII|DA08304086‏
996 ‎‡2 NTA|086635972‏
996 ‎‡2 ISNI|0000000363749345‏
996 ‎‡2 DBC|87097992424014‏
996 ‎‡2 RERO|A009651564‏
996 ‎‡2 DBC|87097968095379‏
996 ‎‡2 PLWABN|9812829524505606‏
996 ‎‡2 DBC|87097991439794‏
996 ‎‡2 BIBSYS|97014629‏
996 ‎‡2 BIBSYS|90252333‏
996 ‎‡2 ISNI|0000000481256621‏
996 ‎‡2 DBC|87097968392217‏
996 ‎‡2 J9U|987008729297805171‏
996 ‎‡2 DBC|87097962785063‏
996 ‎‡2 DNB|1066611726‏
996 ‎‡2 RERO|A009049384‏
996 ‎‡2 LC|no2023130984‏
996 ‎‡2 NKC|jo20191026817‏
996 ‎‡2 DBC|870979138790738‏
996 ‎‡2 ISNI|0000000110718276‏
996 ‎‡2 DNB|1058349015‏
996 ‎‡2 LC|no2002033061‏
996 ‎‡2 LC|n 2012026586‏
996 ‎‡2 DBC|87097962614773‏
996 ‎‡2 LC|n 98004925‏
996 ‎‡2 BIBSYS|1060368‏
996 ‎‡2 ISNI|000000051434715X‏
996 ‎‡2 DBC|87097968537487‏
996 ‎‡2 BIBSYS|13065177‏
996 ‎‡2 ISNI|0000000040821410‏
996 ‎‡2 ISNI|0000000035397774‏
996 ‎‡2 BIBSYS|13048593‏
996 ‎‡2 DBC|87097968162661‏
996 ‎‡2 BNC|981058612191206706‏
996 ‎‡2 ISNI|0000000054721488‏
996 ‎‡2 SUDOC|074543482‏
996 ‎‡2 DBC|87097968392349‏
996 ‎‡2 PLWABN|9810642824105606‏
996 ‎‡2 NTA|071377255‏
996 ‎‡2 SUDOC|26606647X‏
996 ‎‡2 LC|nb2005009130‏
996 ‎‡2 RERO|A003346564‏
996 ‎‡2 RERO|A003346565‏
996 ‎‡2 RERO|A003346566‏
996 ‎‡2 BIBSYS|14010479‏
996 ‎‡2 DBC|87097969843093‏
996 ‎‡2 BIBSYS|1642068437332‏
996 ‎‡2 DNB|1057533122‏
996 ‎‡2 BIBSYS|99067533‏
996 ‎‡2 BIBSYS|1052930‏
996 ‎‡2 DNB|11899719X‏
996 ‎‡2 BIBSYS|11037701‏
996 ‎‡2 LC|no2016072911‏
996 ‎‡2 DBC|87097968397685‏
996 ‎‡2 DBC|87097919105393‏
996 ‎‡2 BIBSYS|4001150‏
996 ‎‡2 BIBSYS|15041231‏
996 ‎‡2 W2Z|1479731351118‏
996 ‎‡2 DNB|1347887954‏
996 ‎‡2 LC|nr 94007889‏
996 ‎‡2 BIBSYS|5092983‏
996 ‎‡2 J9U|987012469332105171‏
996 ‎‡2 DBC|87097968397693‏
996 ‎‡2 NTA|072277211‏
996 ‎‡2 LC|no2020027067‏
996 ‎‡2 SUDOC|157037851‏
996 ‎‡2 W2Z|1642068437332‏
996 ‎‡2 DBC|87097946414977‏
996 ‎‡2 DBC|87097968392330‏
996 ‎‡2 DNB|116332476‏
996 ‎‡2 ISNI|0000000117288627‏
996 ‎‡2 ISNI|0000000444841530‏
996 ‎‡2 DBC|87097939373084‏
996 ‎‡2 ISNI|0000000513307754‏
996 ‎‡2 DBC|87097969978487‏
996 ‎‡2 LC|n 2024064242‏
996 ‎‡2 PLWABN|9813276154405606‏
996 ‎‡2 NTA|442538472‏
996 ‎‡2 BIBSYS|41894‏
996 ‎‡2 LC|n 97051174‏
996 ‎‡2 W2Z|4029290‏
996 ‎‡2 DNB|1158262981‏
996 ‎‡2 NTA|432212833‏
996 ‎‡2 LC|nb2004310268‏
996 ‎‡2 W2Z|13057607‏
996 ‎‡2 CAOONL|ncf10163810‏
996 ‎‡2 BIBSYS|15330‏
996 ‎‡2 DBC|87097969558844‏
996 ‎‡2 LC|no2008094050‏
996 ‎‡2 BIBSYS|4074370‏
996 ‎‡2 LC|n 79021676‏
996 ‎‡2 J9U|987007299340405171‏
996 ‎‡2 DNB|171740688‏
996 ‎‡2 J9U|987007461441705171‏
996 ‎‡2 ISNI|0000000365440077‏
996 ‎‡2 DBC|87097919103080‏
996 ‎‡2 SELIBR|199332‏
996 ‎‡2 ISNI|0000000055541972‏
996 ‎‡2 NUKAT|n 02062614‏
996 ‎‡2 CAOONL|ncf10224782‏
996 ‎‡2 BIBSYS|99058370‏
996 ‎‡2 LC|n 2008077474‏
996 ‎‡2 DBC|87097968159482‏
996 ‎‡2 W2Z|90352800‏
996 ‎‡2 KRNLK|KAC200912469‏
996 ‎‡2 J9U|987012749347805171‏
996 ‎‡2 NUKAT|n 2011113262‏
996 ‎‡2 ISNI|0000000432733778‏
996 ‎‡2 BIBSYS|7033936‏
996 ‎‡2 BIBSYS|4050397‏
996 ‎‡2 BIBSYS|90860850‏
996 ‎‡2 DBC|87097968397499‏
996 ‎‡2 LC|n 86098146‏
996 ‎‡2 SUDOC|167648799‏
996 ‎‡2 LC|n 96120945‏
996 ‎‡2 BIBSYS|1067479‏
996 ‎‡2 DBC|87097969308783‏
996 ‎‡2 RERO|A027724363‏
996 ‎‡2 DNB|1017190879‏
996 ‎‡2 BIBSYS|1092817‏
996 ‎‡2 DBC|87097948651216‏
996 ‎‡2 DNB|117123385X‏
996 ‎‡2 BIBSYS|4105981‏
996 ‎‡2 ISNI|0000000074862448‏
996 ‎‡2 BIBSYS|90951274‏
996 ‎‡2 SUDOC|198594895‏
996 ‎‡2 BNE|XX1416308‏
996 ‎‡2 DNB|116455527‏
996 ‎‡2 DBC|870979137453207‏
996 ‎‡2 BIBSYS|97014459‏
996 ‎‡2 NUKAT|n 2012244313‏
996 ‎‡2 ISNI|0000000481144005‏
996 ‎‡2 RERO|A027526758‏
996 ‎‡2 ISNI|0000000035058836‏
996 ‎‡2 BIBSYS|11039731‏
996 ‎‡2 BIBSYS|5058070‏
996 ‎‡2 NUKAT|n 2004039797‏
996 ‎‡2 BIBSYS|13004455‏
996 ‎‡2 BIBSYS|99015626‏
996 ‎‡2 ISNI|0000000486324283‏
996 ‎‡2 ISNI|0000000485672956‏
996 ‎‡2 NUKAT|n 2019214201‏
996 ‎‡2 CAOONL|ncf11633927‏
996 ‎‡2 LC|n 85119693‏
996 ‎‡2 ISNI|0000000082137553‏
996 ‎‡2 BIBSYS|4107229‏
996 ‎‡2 DBC|87097968085063‏
996 ‎‡2 DBC|87097968397707‏
996 ‎‡2 ISNI|0000000035252399‏
996 ‎‡2 LC|n 2023052458‏
996 ‎‡2 DNB|1293523380‏
996 ‎‡2 BIBSYS|9050658‏
996 ‎‡2 LC|n 2012052969‏
996 ‎‡2 BIBSYS|11003874‏
996 ‎‡2 DBC|87097946660838‏
996 ‎‡2 BNF|15087099‏
996 ‎‡2 BIBSYS|3013801‏
996 ‎‡2 DBC|87097969267815‏
996 ‎‡2 DBC|870979135444774‏
996 ‎‡2 BIBSYS|4029290‏
996 ‎‡2 BIBSYS|90744000‏
996 ‎‡2 LC|n 88178932‏
996 ‎‡2 LC|no2008096853‏
996 ‎‡2 BIBSYS|3112817‏
996 ‎‡2 BIBSYS|11056662‏
996 ‎‡2 DNB|134612973‏
996 ‎‡2 BIBSYS|1045032‏
996 ‎‡2 PLWABN|9813318184605606‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏